Whitepaper
An emerging therapeutic modality - RNA carves its path out of the paradigm
RNA-based therapeutics have garnered significant attention in recent years, fueled by the success of the mRNA COVID-19 vaccines. The development of therapeutics for a broad range of other conditions, including monogenic diseases, metabolic disorders, and cancer, are now being made possible due to advances in RNA-mediated genome editing tools and technologies.
Considering the growing interest in RNA therapies, our latest article highlights several promising classes of RNA therapeutic, including RNAi, CRISPR, base editing, and mRNA vaccines, as well as the potential to combine RNA technologies with CAR-T.
For research use only. Not for use in diagnostic procedures.
To view the full content please answer a few questions
Download Resource
An emerging therapeutic modality - RNA carves its path out of the paradigm